Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Developme... ( RESEARCH TRIANGLE PARK N.C. March...)

Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer

Date:3/14/2013

RESEARCH TRIANGLE PARK, N.C., March 14, 2013 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that Michael D. Rogers , Ph.D., has joined the company as Chief Development Officer. Dr. Rogers will be responsible for overseeing chemistry, manufacturing, toxicology and project management as well as the advancement of compounds from the Chimerix Chemical Library.

"We are extremely pleased to have Mike join our management team," said Kenneth I. Moch , Chimerix President and Chief Executive Officer. "His proven track record and extensive experience designing and leading successful antiviral development programs will be of significant benefit as we advance our lead compound, CMX001, into Phase 3 clinical testing."

Dr. Rogers was formerly Chief Development Officer at Pharmasset, Inc., a company which pioneered the use of nucleotide analogs for the treatment of Hepatitis C virus (HCV), until its acquisition by Gilead Sciences, Inc. in January 2012. During his five years at Pharmasset, Dr. Rogers was responsible for development, regulatory and portfolio management activities.

Prior to joining Pharmasset, Dr. Rogers held several positions in antiviral discovery and development at GlaxoSmithKline, including serving as Vice President, Division of Viral Diseases, where he was responsible for antiviral discovery activities directed toward human immunodeficiency virus (HIV) and HCV indications. In addition, he has led numerous anti-infective projects that resulted in successful commercialization. During his career, he has led multinational development teams from discovery to marketing and has a successful product development record, including Lexiva(R) and the approvals for Agenerase(R), Mepron(R) and Malarone(R).

Dr. Rogers earned his M
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
2. Chimerix Files Registration Statement for Proposed Initial Public Offering
3. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
4. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
5. Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
6. Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV
7. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
8. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
9. Vermillion Appoints Thomas McLain as President and Chief Executive Officer
10. Echo Therapeutics Appoints Robert Doman to Board of Directors
11. CIVCO Appoints Hap Peterson Vice President of North American Sales for Radiation Oncology

Post Your Comments:

(Date:5/17/2013)... Research explores data on ... also to be presented ... the global specialty biopharmaceutical company, announces that it will ... American Psychiatric Association (APA) 166th Annual Meeting in ... being presented represent Shire,s ongoing commitment to the clinical ...

(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...

(Date:5/17/2013)... , May 17, 2013 Boehringer Ingelheim ... respiratory disease at the American Thoracic Society International ... , May 17 – 22. ... approved for the treatment of chronic obstructive pulmonary ... as well as investigational compounds for asthma, idiopathic ...

[0] Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting [0] Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment [0] Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference

... As part of a three-year global initiative to identify ... problems around the world, Boehringer Ingelheim and Ashoka,s Changemakers® ... Health: Achieving Individual, Family, and Community Well-Being ... the most innovative models and solutions that are transforming ...

... Ascension Orthopedics, Inc., a world leader in PyroCarbon orthopedic ... Glenoid. The Mini Glenoid is yet another addition to the ... way to address glenoid arthritis. "The Mini ... the glenoid as well as load-share with the peripheral glenoid ...

Cached Medicine Technology:Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 2 Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 3 Ascension Orthopedics Announces Market Release of TITAN™ Inset Mini Glenoid 2

Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition Ascension Orthopedics Announces Market Release of TITAN™ Inset Mini Glenoid

(Date:5/19/2013)... 2013 The legal team at Pulaski ... a concerted effort to connect women and families coping ... drugs Yaz, Yasmin & Ocella with the legal representation ... on the notorious birth control drugs as well as ... , Yaz, Yasmin & Ocella were very popular birth ...

(Date:5/18/2013)... (PRWEB) May 18, 2013 Daily Gossip issued ... a new review on their page. John Colston, Daily Gossip’s ... to Shaun Hadsall’s revolutionizing 14-Day Rapid Fat Loss Plan ... sustain that carbs are healthy at a time when nutritionists ... from highly caloric products. , The diet is based ...

(Date:5/18/2013)... Also known as bariatric surgery , ... surgery that guarantees patients long-term weight loss. Dr. Naim ... give readers a brief tutorial on this revolutionary weight ... New York City’s Mount Sinai School of Medicine. After ... fellowship in Minimally Invasive Bariatric Surgery. He has also ...

(Date:5/18/2013)... Children who swallow high-powered magnets often need surgery and ... a new study. The researchers, from the Louisiana ... more than 79 percent of children who swallowed very ... procedure, in which a tube containing a camera is ... these cases can be treated through observation or by ...

(Date:5/18/2013)... There are significant cost and risk factors ... or treat gastrointestinal problems, according to research presented ... study by New York Presbyterian Hospital and Weill-Cornell ... substantially reduce the cost and risk of managing ... to affect nearly 25 percent of adults, researchers ...

Breaking Medicine News(10 mins):Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2 Health News:Everything You Need to Know About Lap Band Surgery 2 Health News:Everything You Need to Know About Lap Band Surgery 3 Health News:Swallowing Magnets Can Be Fatal for Children 2 Health News:New research identifies practice changes to improve value and quality of GI procedures 2

[0] Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers [0] 14 Day Rapid Fat Loss Plan Review of Shaun Hadsall's Diet and Workout Secrets Revealed By Daily Gossip [0] Everything You Need to Know About Lap Band Surgery [0] Swallowing Magnets Can Be Fatal for Children [0] New research identifies practice changes to improve value and quality of GI procedures

... , TUESDAY, Aug. 16 (HealthDay News) -- For some ... of the disease who find standard treatments either intolerable ... relief. A new injectable treatment called pegloticase (brand ... patients, but researchers say that for the roughly ...

... Pneumonia kills more children around the world than any ... the causes of childhood pneumonia across many countries was ... study called the Pneumonia Etiology Research for Child Health ... 5 African and 2 Asian research sites coordinated by ...

... was a dramatic increase in the number of children,s flu-related hospital ... agency says. Over that time, flu rose from 65th to ... younger go to the hospital, according to a report from the ... found that skin infections rose from 13th to 7th in the ...

... Foundation launched a major new collaboration created with ... with its announcement that it will provide funding ... interventional radiology during 2012󈝹 in the Howard Hughes ... "The SIR Foundation, which seeks to further ...

... new study has shown the Flexible-Fiber CO2 laser to ... (TSC) without the,line of sight problems encountered with conventional ... Medical Center (BMC) and Boston University School of Medicine ... Neurosurgery . This is the first study to report ...

... for 15 minutes a day, or 92 minutes per week, ... who are inactive, according to a study published today in ... reduced deaths from any cause by 14 percent," said study ... The University of Texas MD Anderson Cancer Center Department of ...

Cached Medicine News:Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 2 Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 3 Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 4 Health News:Largest global childhood pneumonia etiology study launched 2 Health News:Largest global childhood pneumonia etiology study launched 3 Health News:Society of Interventional Radiology Foundation funds Howard Hughes Medical Institute Award 2 Health News:Study finds flexible-fiber CO2 laser safe in endoscopic endonasal transsphenoidal surgery 2 Health News:Study finds 15 minutes of moderate daily exercise lengthens life 2 Health News:Study finds 15 minutes of moderate daily exercise lengthens life 3

New Drug May Relieve Severe, Tough-to-Treat Gout Largest global childhood pneumonia etiology study launched More Kids Hospitalized for Flu, Skin Infections Society of Interventional Radiology Foundation funds Howard Hughes Medical Institute Award Study finds flexible-fiber CO2 laser safe in endoscopic endonasal transsphenoidal surgery Study finds 15 minutes of moderate daily exercise lengthens life

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Cr, Blood Coxiella burnetii IgM Antibody, IFA Coxsackie A9 Virus Antibodies by CF Coxiellaburnetii (Q-Fever) Antibody IgG, Phase II by IFA